Actuate Therapeutics Inc (ACTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,285 | -20,839 | -14,868 | -8,296 | -24,745 |
| Accounts payable and accrued liabilities | -1,501 | -1,198 | 2,413 | 484 | N/A |
| Other Working Capital | 1,100 | 623 | 5,026 | 2,363 | 2,572 |
| Other Operating Activity | 5,843 | 4,344 | -491 | 202 | 548 |
| Operating Cash Flow | $-21,843 | $-17,070 | $-7,921 | $-5,248 | $-21,625 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 200 | 200 | N/A | N/A | N/A |
| Debt Issued | 5,500 | 5,500 | 5,500 | 4,500 | N/A |
| Common Stock Issued | 23,957 | 23,957 | N/A | N/A | N/A |
| Other Financing Activity | -2,131 | -2,022 | -186 | -143 | 4,135 |
| Financing Cash Flow | $27,526 | $27,635 | $5,314 | $4,357 | $4,135 |
| Beginning Cash Position | 2,959 | 2,959 | 2,959 | 2,959 | 20,449 |
| End Cash Position | 8,642 | 13,524 | 352 | 2,068 | 2,959 |
| Net Cash Flow | $5,683 | $10,565 | $-2,607 | $-890 | $-17,491 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,843 | -17,070 | -7,921 | -5,248 | -21,625 |
| Free Cash Flow | -21,843 | -17,070 | -7,921 | -5,248 | -21,625 |